Aclarion's CEO Brent Ness to Attend LSI USA 2026 Conference

jueves, 12 de marzo de 2026, 6:02 am ET1 min de lectura
ACON--

Aclarion CEO Brent Ness will attend LSI USA 2026 to discuss the company's progress on NOCISCAN, a proprietary MR spectroscopy platform that uses AI and biomarkers to help physicians identify the source of chronic low back pain. The platform distinguishes between painful and non-painful discs, giving physicians clarity to optimize treatment strategies. The conference is a premier event focused on accelerating MedTech and HealthTech innovation, bringing together investors, startups, and industry leaders.

Aclarion's CEO Brent Ness to Attend LSI USA 2026 Conference

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios